BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16089017)

  • 1. [Hypothyroidism and lovastatin-induced myositis].
    Rodríguez Framil M; Martínez Rey C; Alende Sixto MR; Torre Carballada JA
    An Med Interna; 2005 May; 22(5):252-3. PubMed ID: 16089017
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myopathy linked to statins in a patient with recently appeared hypothyroidism].
    León Rodríguez C; Martínez González M
    Aten Primaria; 2005; 36(3):171-2. PubMed ID: 16029751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins Can Lead to Acute Hemolysis.
    Moghadasi M; Maghsoomi Z
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):123. PubMed ID: 30741131
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypothyroidism, pravastatin therapy and myopathy].
    Porela P; Kantola I
    Duodecim; 2002; 118(7):689-90. PubMed ID: 12238178
    [No Abstract]   [Full Text] [Related]  

  • 5. Lovastatin: an HMG-CoA reductase inhibitor for lowering cholesterol.
    Frishman WH; Rapier RC
    Med Clin North Am; 1989 Mar; 73(2):437-48. PubMed ID: 2645482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lovastatin for hypercholesterolemia.
    Med Lett Drugs Ther; 1987 Nov; 29(752):99-101. PubMed ID: 3312981
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis and rhabdomyolysis in a patient with hormone refractory prostate cancer on ketoconazole and concurrent lovastatin therapy.
    Stein CA; Goel S; Ghavamian R
    Invest New Drugs; 2007 Jun; 25(3):277-8. PubMed ID: 17216557
    [No Abstract]   [Full Text] [Related]  

  • 8. HMG-CoA reductase inhibitors. A new approach to the management of hypercholesterolemia.
    Cressman MD; Hoogwerf BJ; Moodie DS; Olin JW; Weinstein CE
    Cleve Clin J Med; 1988; 55(1):93-100. PubMed ID: 3277742
    [No Abstract]   [Full Text] [Related]  

  • 9. Lichenoid drug eruption with HMG-CoA reductase inhibitors (fluvastatin and lovastatin).
    Sebök B; Tóth M; Anga B; Harangi F; Schneider I
    Acta Derm Venereol; 2004; 84(3):229-30. PubMed ID: 15202842
    [No Abstract]   [Full Text] [Related]  

  • 10. The almost forgotten biological potentials of cholesterol and its intermediates: cholesterol reduction and myositis.
    Twickler M; Banga JD; Cramer MJ
    Cardiovasc Drugs Ther; 2003; 17(5-6):395-6. PubMed ID: 15112678
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of statins: effects on muscle and the liver.
    Vasudevan AR; Hamirani YS; Jones PH
    Cleve Clin J Med; 2005 Nov; 72(11):990-3, 996-1001. PubMed ID: 16315438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.
    Tobert JA
    Nat Rev Drug Discov; 2003 Jul; 2(7):517-26. PubMed ID: 12815379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypercholesterolemia, rhabdomyolysis and hypothyroidism].
    Polo Romero FJ; Beato Pérez JL
    Rev Clin Esp; 2003 Mar; 203(3):163-4. PubMed ID: 12646090
    [No Abstract]   [Full Text] [Related]  

  • 14. Worldwide experience with simvastatin/lovastatin.
    Walker JF
    Eur Heart J; 1992 Jul; 13 Suppl B():21-2. PubMed ID: 1644097
    [No Abstract]   [Full Text] [Related]  

  • 15. Pravastatin, simvastatin, and lovastatin for lowering serum cholesterol concentrations.
    Med Lett Drugs Ther; 1992 Jun; 34(872):57-8. PubMed ID: 1593973
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypothyroid myopathy manifesting as severe rhabdomyolysis in the context of autoimmune thyroiditis].
    Astudillo L; Godel A; Bennet A; Couret B; Arlet-Suau E
    Presse Med; 2003 May; 32(18):843. PubMed ID: 12870388
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative efficacy and tolerability of low-dose pravastatin versus lovastatin in patients with hypercholesterolemia.
    Strauss WE; Lapsley D; Gaziano JM
    Am Heart J; 1999 Mar; 137(3):458-62. PubMed ID: 10047626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical efficacy and safety of lovastatin and MK-733--an overview.
    Walker JF; Tobert JA
    Eur Heart J; 1987 Aug; 8 Suppl E():93-6. PubMed ID: 3315683
    [No Abstract]   [Full Text] [Related]  

  • 19. Pravastatin-associated myopathy. Report of a case.
    Scalvini T; Marocolo D; Cerudelli B; Sleiman I; Balestrieri GP; Giustina G
    Recenti Prog Med; 1995 May; 86(5):198-200. PubMed ID: 7604176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibitors reduce stroke risk, total mortality.
    Am J Health Syst Pharm; 1997 Oct; 54(19):2152, 2154. PubMed ID: 9331434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.